Investors

Event Details

Feb 21, 2023 9:00 AM EST

Bruce Jacobs, CFA, MBA
Chief Financial Officer
investors@kymeratx.com

Christopher F. Brinzey
Westwicke, an ICR Company for Kymera Therapeutics
chris.brinzey@westwicke.com
+ 1 339.970.2843

Todd Cooper
Sr. Vice President, Corporate Affairs
media@kymeratx.com